These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9691832)
61. New insights into vitamin D anticancer properties: focus on miRNA modulation. Zeljic K; Supic G; Magic Z Mol Genet Genomics; 2017 Jun; 292(3):511-524. PubMed ID: 28243735 [TBL] [Abstract][Full Text] [Related]
62. Vitamin D and vitamin D analogs as cancer chemopreventive agents. Guyton KZ; Kensler TW; Posner GH Nutr Rev; 2003 Jul; 61(7):227-38. PubMed ID: 12918875 [TBL] [Abstract][Full Text] [Related]
63. Mechanism of action of Vitamin D. Franceschi RT Wis Med J; 1981 Oct; 80(10):17. PubMed ID: 6896106 [No Abstract] [Full Text] [Related]
64. Strengths and limitations of current epidemiologic studies: vitamin D as a modifier of colon and prostate cancer risk. Giovannucci E Nutr Rev; 2007 Aug; 65(8 Pt 2):S77-9. PubMed ID: 17867375 [No Abstract] [Full Text] [Related]
65. Vitamin D: metabolism, molecular mechanisms, and mutations to malignancies. Nemazannikova N; Antonas K; Dass CR Mol Carcinog; 2014 Jun; 53(6):421-31. PubMed ID: 23359295 [TBL] [Abstract][Full Text] [Related]
66. The roles of vitamin D in seborrhoeic keratosis: possible genetic and cellular signalling mechanisms. Lu'o'ng Kv; Nguyễn LT Int J Cosmet Sci; 2013 Dec; 35(6):525-31. PubMed ID: 23859137 [TBL] [Abstract][Full Text] [Related]
67. Vitamin D metabolism and action. Bouillon R; Carmeliet G; Daci E; Segaert S; Verstuyf A Osteoporos Int; 1998; 8 Suppl 2():S13-9. PubMed ID: 10197177 [No Abstract] [Full Text] [Related]
68. New ligands for defective receptors. Habeck M Drug Discov Today; 2003 Mar; 8(6):236-7. PubMed ID: 12623229 [TBL] [Abstract][Full Text] [Related]
69. The role of vitamin D in polycystic ovary syndrome. Lin MW; Wu MH Indian J Med Res; 2015 Sep; 142(3):238-40. PubMed ID: 26458338 [No Abstract] [Full Text] [Related]
70. Very important pharmacogene summary for VDR. Poon AH; Gong L; Brasch-Andersen C; Litonjua AA; Raby BA; Hamid Q; Laprise C; Weiss ST; Altman RB; Klein TE Pharmacogenet Genomics; 2012 Oct; 22(10):758-63. PubMed ID: 22588316 [No Abstract] [Full Text] [Related]
71. [Vitamin D and metabolic, autoimmunologic and neoplasm diseases]. Galant K; Barg E; Kazanowska B Pediatr Endocrinol Diabetes Metab; 2016; 22(1):32-38. PubMed ID: 28132071 [TBL] [Abstract][Full Text] [Related]
72. Endocrine functions of vitamin D. Carlberg C Mol Cell Endocrinol; 2017 Sep; 453():1-2. PubMed ID: 28669826 [No Abstract] [Full Text] [Related]
73. A novel therapeutic target of spontaneous bacterial peritonitis: skewing M2 polarization through vitamin D-VDR-IL-37 pathway. Zhou D; Wang Y; Zhang W; Luan J Liver Int; 2016 Feb; 36(2):313. PubMed ID: 26256484 [No Abstract] [Full Text] [Related]
74. Mechanisms of neuroprotective action of vitamin D(3). Kalueff AV; Eremin KO; Tuohimaa P Biochemistry (Mosc); 2004 Jul; 69(7):738-41. PubMed ID: 15310271 [TBL] [Abstract][Full Text] [Related]
75. Vitamin D resistance. Malloy PJ; Feldman D Am J Med; 1999 Mar; 106(3):355-70. PubMed ID: 10190386 [No Abstract] [Full Text] [Related]
76. Vitamin D and the lymphomedullary system. Lancet; 1984 May; 1(8386):1105-6. PubMed ID: 6144832 [No Abstract] [Full Text] [Related]
77. [Vitamin D and prostate cancer]. Marusić G; Jeremić D; Vojinov S; Filipović N; Popov M Med Pregl; 2013; 66(5-6):259-62. PubMed ID: 23888737 [TBL] [Abstract][Full Text] [Related]
78. Vitamin D: Mechanisms of Action and Clinical Applications. Gallagher JC; Bikle DD Endocrinol Metab Clin North Am; 2017 Dec; 46(4):xvii-xviii. PubMed ID: 29080648 [No Abstract] [Full Text] [Related]
79. Vitamin D and Systems Biology. Hussain S; Yates C; Campbell MJ Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558356 [TBL] [Abstract][Full Text] [Related]
80. Vitamin D and prostate cancer. Konety BR; Getzenberg RH Urol Clin North Am; 2002 Feb; 29(1):95-106, ix. PubMed ID: 12109360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]